Oxidized low-density lipoprotein potentiates angiotensin II-induced Gq activation through the AT1-LOX1 receptor complex
Open Access
- 25 March 2025
- journal article
- research article
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Abstract
Chronic kidney disease (CKD) and atherosclerotic heart disease, frequently associated with dyslipidemia and hypertension, represent significant health concerns. We investigated the interplay among these conditions, focusing on the role of oxidized low-density lipoprotein (oxLDL) and angiotensin II (Ang II) in renal injury via G protein αq subunit (Gq) signaling. We hypothesized that oxLDL enhances Ang II-induced Gq signaling via the AT1 (Ang II type 1 receptor)-LOX1 (lectin-like oxLDL receptor) complex. Based on CHO and renal cell model experiments, oxLDL alone did not activate Gq signaling. However, when combined with Ang II, it significantly potentiated Gq-mediated inositol phosphate 1 production and calcium influx in cells expressing both LOX-1 and AT1 but not in AT1-expressing cells. This suggests a critical synergistic interaction between oxLDL and Ang II in the AT1-LOX1 complex. Conformational studies using AT1 biosensors have indicated a unique receptor conformational change due to the oxLDL-Ang II combination. In vivo, wild-type mice fed a high-fat diet with Ang II infusion presented exacerbated renal dysfunction, whereas LOX-1 knockout mice did not, underscoring the pathophysiological relevance of the AT1-LOX1 interaction in renal damage. These findings highlight a novel mechanism of renal dysfunction in CKD driven by dyslipidemia and hypertension and suggest the therapeutic potential of AT1-LOX1 receptor complex in patients with these comorbidities.Keywords
All Related Versions
Funding Information
- Japan Society for the Promotion of Science (21K07389)
- Japan Society for the Promotion of Science (22K08181)
- Japan Society for the Promotion of Science (20H03576)
- Japan Society for the Promotion of Science (18H02732)
This publication has 48 references indexed in Scilit:
- Epithelial–mesenchymal plasticity in kidney fibrosisGenesis, 2023
- Cardiovascular angiotensin II type 1 receptor biased signaling: Focus on non-Gq-, non-βarrestin-dependent signalingPharmacological Research, 2021
- KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney DiseaseKidney International, 2021
- The endocytosis of oxidized LDL via the activation of the angiotensin II type 1 receptoriScience, 2021
- Angiotensin Analogs with Divergent Bias Stabilize Distinct Receptor ConformationsCell, 2019
- The Renal Pathology of ObesityKidney International Reports, 2017
- Determination of LOX-1-ligand activity in mouse plasma with a chicken monoclonal antibody for ApoBAtherosclerosis, 2008
- Managing Dyslipidemia in Chronic Kidney DiseaseJACC, 2008
- Crystal Structure of Human Lectin-like, Oxidized Low-Density Lipoprotein Receptor 1 Ligand Binding Domain and Its Ligand Recognition Mode to OxLDLStructure, 2005
- The renin-angiotensin-aldosterone system and the kidney: effects on kidney diseaseThe American Journal of Medicine, 2004